CN87107852A - 含烟碱液态制剂的口服胶囊 - Google Patents
含烟碱液态制剂的口服胶囊 Download PDFInfo
- Publication number
- CN87107852A CN87107852A CN87107852A CN87107852A CN87107852A CN 87107852 A CN87107852 A CN 87107852A CN 87107852 A CN87107852 A CN 87107852A CN 87107852 A CN87107852 A CN 87107852A CN 87107852 A CN87107852 A CN 87107852A
- Authority
- CN
- China
- Prior art keywords
- capsule
- nicotine
- preparation
- oral
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 53
- 229960002715 nicotine Drugs 0.000 title claims abstract description 53
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 239000007788 liquid Substances 0.000 title claims abstract description 6
- 229940100691 oral capsule Drugs 0.000 title claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 7
- 230000014860 sensory perception of taste Effects 0.000 claims abstract description 7
- 239000000654 additive Substances 0.000 claims abstract description 6
- 230000005586 smoking cessation Effects 0.000 claims abstract description 3
- 230000000996 additive effect Effects 0.000 claims description 5
- 238000001125 extrusion Methods 0.000 claims 1
- 238000013467 fragmentation Methods 0.000 claims 1
- 238000006062 fragmentation reaction Methods 0.000 claims 1
- 235000021407 appetite control Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 241000208125 Nicotiana Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000001055 chewing effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000005156 neurotropism Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP3639418.1 | 1986-11-18 | ||
| DE19863639418 DE3639418A1 (de) | 1986-11-18 | 1986-11-18 | Nikotinhaltiges mittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN87107852A true CN87107852A (zh) | 1988-06-22 |
Family
ID=6314221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN87107852A Pending CN87107852A (zh) | 1986-11-18 | 1987-11-18 | 含烟碱液态制剂的口服胶囊 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0324794B1 (https=) |
| JP (1) | JP2602043B2 (https=) |
| CN (1) | CN87107852A (https=) |
| AT (1) | ATE72114T1 (https=) |
| AU (1) | AU622101B2 (https=) |
| BR (1) | BR8707879A (https=) |
| DE (3) | DE3645036A1 (https=) |
| DK (1) | DK173353B1 (https=) |
| WO (1) | WO1988003803A1 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249130B (zh) * | 2008-04-11 | 2011-06-15 | 桂林商源植物制品有限公司 | 一种戒烟并缓解戒烟综合症的药用或保健组合物 |
| CN105341990A (zh) * | 2015-12-16 | 2016-02-24 | 浙江中烟工业有限责任公司 | 一种提升电子烟生理满足感的电子烟烟液 |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
| US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
| DE4440563A1 (de) * | 1994-11-12 | 1996-05-15 | Herzog Sen Rolf | Verfahren und Mittel zum Genuß von Tabak - Nikotin unter Vermeidung schädlicher Verbrennungs - Derivate |
| US5604231A (en) * | 1995-01-06 | 1997-02-18 | Smith; Carr J. | Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| US5846983A (en) * | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
| AU2340397A (en) * | 1996-03-21 | 1997-10-10 | Mayo Foundation For Medical Education And Research | Use of nicotine to treat liver disease |
| GB9614902D0 (en) | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
| AUPO108596A0 (en) * | 1996-07-18 | 1996-08-08 | Collier, Gregory | Treatment of obesity |
| US6211194B1 (en) * | 1998-04-30 | 2001-04-03 | Duke University | Solution containing nicotine |
| US6268386B1 (en) * | 1998-06-25 | 2001-07-31 | Marshall Anlauf Thompson | Nicotine beverage |
| GB2338896B (en) * | 1998-07-02 | 2003-05-21 | Reckitt & Colmann Prod Ltd | Chewable Capsules |
| US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
| ES2313900T3 (es) | 1999-07-28 | 2009-03-16 | The Board Of Trustees Of The Leland Stanford Junior University | Nicotina en angiogenesis y vasculogenesis terapeutica. |
| AT409219B (de) * | 1999-08-13 | 2002-06-25 | Red Bull Gmbh | Verwendung von nikotin zum herstellen von arzneimitteln |
| SE0104388D0 (sv) * | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
| US20040002520A1 (en) * | 2002-07-01 | 2004-01-01 | Soderlund Patrick L. | Composition and method for cessation of Nicotine cravings |
| ES2285233T3 (es) | 2002-12-20 | 2007-11-16 | Niconovum Ab | Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable. |
| IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Insomnia treatment |
| US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
| WO2005007068A1 (en) * | 2003-07-22 | 2005-01-27 | The Kiwigel Company Limited | Nicotine packaging system |
| NO20042835D0 (no) * | 2004-07-05 | 2004-07-05 | Nils-Erik Skeide | Innkapslet tobakksroyk |
| JP5254616B2 (ja) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達 |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| US9402809B2 (en) | 2006-03-16 | 2016-08-02 | Niconovum Usa, Inc. | Snuff composition |
| EP2322168A1 (en) * | 2007-04-02 | 2011-05-18 | Parkinson's Institute | Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments |
| US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
| JP2018511355A (ja) | 2015-01-28 | 2018-04-26 | クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 薬剤送達方法及びシステム |
| AU2016228779A1 (en) | 2015-03-12 | 2017-09-07 | Chrono Therapeutics Inc. | Craving input and support system |
| EP3297676A2 (en) | 2015-05-22 | 2018-03-28 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Combination of trpm8-agonist and nachr-agonist for treatment of obesity and related disorders and for weight reduction |
| EP3565617A1 (en) | 2017-01-06 | 2019-11-13 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| EP3801732A4 (en) | 2018-05-29 | 2022-04-27 | Morningside Venture Investments Limited | METHODS AND SYSTEMS FOR DRUG DELIVERY |
| US12397141B2 (en) | 2018-11-16 | 2025-08-26 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU432703A3 (https=) * | 1971-08-24 | 1974-06-15 | Фридрих Боссерт, Вульф Фатер, Курт Бауер | |
| US3870794A (en) * | 1974-02-20 | 1975-03-11 | Foundation For Behavioral Rese | Treatment of certain emotional disorders with nicotine compounds |
| GB1528391A (en) * | 1976-01-05 | 1978-10-11 | Gildemeister V | Aerosol compositions |
| DE3241437A1 (de) * | 1982-11-10 | 1984-05-10 | Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt | Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern |
| GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
| BE899037A (fr) * | 1984-02-29 | 1984-06-18 | Trenker Ady | Composition a sucer permettant de cesser de fumer |
| DE3438284A1 (de) * | 1984-10-16 | 1985-03-07 | Hans-Harald von 2400 Lübeck Tilly | Nikotinhaltiges depotpflaster |
| EP0186502A3 (en) * | 1984-12-25 | 1986-12-10 | Jano Tyroler | Flavor capsule and method of preparing same |
| US4680172A (en) * | 1985-03-05 | 1987-07-14 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
-
1986
- 1986-11-18 DE DE19863645036 patent/DE3645036A1/de active Granted
- 1986-11-18 DE DE19863639418 patent/DE3639418A1/de active Granted
-
1987
- 1987-11-06 JP JP62506732A patent/JP2602043B2/ja not_active Expired - Lifetime
- 1987-11-06 DE DE8787907302T patent/DE3776574D1/de not_active Expired - Fee Related
- 1987-11-06 BR BR8707879A patent/BR8707879A/pt not_active Application Discontinuation
- 1987-11-06 WO PCT/DE1987/000507 patent/WO1988003803A1/de not_active Ceased
- 1987-11-06 EP EP87907302A patent/EP0324794B1/de not_active Expired - Lifetime
- 1987-11-06 AT AT87907302T patent/ATE72114T1/de not_active IP Right Cessation
- 1987-11-06 AU AU81712/87A patent/AU622101B2/en not_active Ceased
- 1987-11-18 CN CN87107852A patent/CN87107852A/zh active Pending
-
1988
- 1988-07-08 DK DK198803858A patent/DK173353B1/da not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249130B (zh) * | 2008-04-11 | 2011-06-15 | 桂林商源植物制品有限公司 | 一种戒烟并缓解戒烟综合症的药用或保健组合物 |
| CN105341990A (zh) * | 2015-12-16 | 2016-02-24 | 浙江中烟工业有限责任公司 | 一种提升电子烟生理满足感的电子烟烟液 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3639418C2 (https=) | 1989-08-03 |
| JPH02501304A (ja) | 1990-05-10 |
| AU8171287A (en) | 1988-06-16 |
| WO1988003803A1 (fr) | 1988-06-02 |
| DK385888D0 (da) | 1988-07-08 |
| DE3776574D1 (de) | 1992-03-12 |
| DK385888A (da) | 1988-07-08 |
| DK173353B1 (da) | 2000-08-07 |
| BR8707879A (pt) | 1989-10-03 |
| AU622101B2 (en) | 1992-04-02 |
| ATE72114T1 (de) | 1992-02-15 |
| DE3645036A1 (de) | 1989-01-05 |
| EP0324794B1 (de) | 1992-01-29 |
| EP0324794A1 (de) | 1989-07-26 |
| DE3639418A1 (de) | 1988-06-09 |
| JP2602043B2 (ja) | 1997-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN87107852A (zh) | 含烟碱液态制剂的口服胶囊 | |
| CA1333051C (en) | Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method | |
| US6893654B2 (en) | Two-stage transmucosal medicine delivery system for symptom relief | |
| CN102770138B (zh) | 含有尼古丁的软凝胶锭剂 | |
| Gourlay et al. | Antismoking products | |
| KR950700055A (ko) | 금연을 돕는 조성물(composition to help stop smoking) | |
| KR101760972B1 (ko) | 합성 장뇌에 의한 원치 않는 감각 효과의 억제 | |
| US4778677A (en) | Method for treatment of nicotine craving | |
| Barsan et al. | Duration of antagonistic effects of nalmefene and naloxone in opiate-induced sedation for emergency department procedures | |
| US6409991B1 (en) | Treatment and system for nicotine withdrawal | |
| RU2445971C2 (ru) | Водный экстракт листьев табака и его применение при лечении зависимости | |
| US2600700A (en) | Composition for alleviation of the tobacco habit | |
| RU2745039C1 (ru) | Никотинсодержащая съедобная бумага | |
| WO2018169387A1 (en) | Tobacco- and smoke-less products consumable by humans as epicurean or medical products and method of treating smoking addiction | |
| Rosenberg | An investigation into the effect on cigarette smoking of a new anti-smoking chewing gum | |
| JPH01197435A (ja) | 含水性喫煙代用貼付剤 | |
| EP0450253B1 (de) | Mittel zur Entwöhnung des Tabakgenusses | |
| US20050045197A1 (en) | Multiple drug delivery system & method | |
| RU2235542C1 (ru) | Способ лечения табакокурения | |
| CN102697960A (zh) | 一种治疗复发性口腔溃疡的药物及其制备方法 | |
| RU2077324C1 (ru) | Способ лечения алкоголизма и никотиномании | |
| Jain et al. | Nicotine chewing gum remedial approach against smoking and chewing habits | |
| US20220175755A1 (en) | Methods of treating tobacco smoking addiction, and treating nicotine and tobacco smoking addiction | |
| CN1311022A (zh) | 速效戒烟戒毒养生液及制备方法 | |
| Burmaka et al. | METHOD OF TREATMENT FOR NICOTINE ADDICTION PATENTED IN UKRAINE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication |